Genalyte
Lab results in under 30 minutes, right in your clinic.
San Diego, United States · Founded 2007 · $164.8M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- genalyte.com
- Total Funding
- $164.8M
- Last Round
- $67.0M Series CMar 2023
- Rounds
- 4
About
Genalyte builds point-of-care lab testing systems that deliver 90% of clinical lab results in under 30 minutes without leaving the clinic. Its flagship Merlin platform is a fully automated, onsite blood testing machine using silicon photonic microring sensor technology. The company submitted the Merlin device to the FDA for premarket clearance in 2025 and is part of the MedTech Innovator accelerator.
Summary
Genalyte is a Biotech company based in San Diego, United States, founded in 2007. It has raised $164.8M in total across 4 rounds, most recently a $67.0M Series C round in Mar 2023. Investors include Verily Life Sciences, Boutique Venture Partners and Khosla Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2023
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...